Genomic Applications Manager
Location: Oxford, UK
Work Type & Model: Hybrid - FTC (Maternity Cover)
We are looking for a highly motivated individual to join our UK Applications team for maternity cover as a Genomic Applications Manager. This role will be based in Oxford and the successful candidate will lead and manage a proof-of-concept team.
About Oxford Nanopore Technologies
Oxford Nanopore Technologies is headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices and a commercial presence in many global locations across the US, APAC, and Europe. Our goal is to enable the analysis of any living thing, by anyone, anywhere.
We employ individuals from multiple subject areas, including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing, and commercialisation. Our sequencing platform is the only technology that offers real-time analysis, in fully scalable formats from pocket to population scale. This platform can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths.
We aim to inspire anyone to sequence anything, anywhere. Do you want to be part of that?
Role Summary:
Reporting to the Snr. Director, Genomic Applications, the successful candidate will lead and manage a team responsible for delivering proof-of-concept studies across a range of applied market segments. The team will evaluate the performance of nanopore sequencing in new applications, identify technical or workflow gaps, and provide initial solutions or assessments of how these gaps can be addressed.
This role will involve designing and overseeing experimental studies, analysing results, and generating high-quality data packages and presentations to support internal decision making and customer engagement. The successful candidate will work closely with cross-functional teams in Oxford to remain aligned with the latest technology developments and to help assess the suitability of emerging nanopore capabilities for new applications and markets.
Other responsibilities include:
Leading and managing a laboratory-based proof-of-concept team within Genomic Applications
Designing and executing proof-of-concept studies to evaluate nanopore sequencing performance in new applied market applications
Identifying workflow, assay, or technology gaps and proposing potential solutions or development pathways
Supporting the assessment and early-stage development of new sequencing applications using ONT’s nanopore platform
Preparation and QC of sequencing analytes and libraries for experimental studies
Analysing and interpreting experimental data, including basic bioinformatic analysis where appropriate
Generating clear summaries, reports, and presentation materials to communicate findings to internal stakeholders
Collaborating with internal scientific and product development teams to support application evaluation and technology adoption
Managing laboratory activities, supporting team development, and assisting junior scientists with experimental and analytical tasks
Contributing to the continuous improvement of laboratory workflows, experimental design, and proof-of-concept evaluation processes
What We're Looking For...
We'll expect you to have undertaken successful experimental research from initial concept through to execution and interpretation. This should include experience with DNA and/or RNA manipulation and preferably next-generation sequencing technologies. You will have strong knowledge of molecular biology techniques and sequencing workflows, including sample preparation, library preparation, and quality control methods.
Experience in evaluating new technologies, troubleshooting experimental workflows, and identifying practical solutions to technical challenges would be highly advantageous. You should be comfortable working across multiple projects simultaneously and capable of leading and motivating a scientific team in a fast-paced environment.
In addition, you will possess excellent communication and problem-solving skills and be able to clearly present scientific findings to a range of audiences. A PhD in molecular biology, genetics, genomics, microbiology, or a related discipline is required, ideally alongside relevant postdoctoral and/or biotechnology industry experience.
This role will suit a proactive, organised, and scientifically curious individual with a collaborative approach and the ability to lead effectively in a dynamic environment.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.
#LI-LH1
#LI-hybrid
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Skills Required
- PhD in molecular biology, genetics, genomics, microbiology, or related discipline
- Proven experience designing, executing, and interpreting experimental research from concept to completion
- Strong knowledge and hands-on experience with DNA and/or RNA manipulation and sequencing workflows
- Experience with sample preparation, library preparation, and sequencing quality control methods
- Experience analysing and interpreting experimental data, including basic bioinformatic analysis
- Experience leading and managing a laboratory team and mentoring junior scientists
- Experience evaluating new technologies, troubleshooting workflows, and proposing practical solutions
- Postdoctoral and/or biotechnology industry experience
- Prior experience with nanopore sequencing platforms
- Excellent communication and presentation skills for scientific audiences
Oxford Nanopore Technologies Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Oxford Nanopore Technologies and has not been reviewed or approved by Oxford Nanopore Technologies.
-
Fair & Transparent Compensation — Pay is considered good to above average across many roles, with employer-provided ranges visible for several U.S. commercial and applications positions and company materials emphasizing market‑competitive base pay. Commercial and some senior technical posts, particularly in the U.S., are positioned as competitive and often paired with strong variable components.
-
Equity Value & Accessibility — All‑employee share plans in the UK and a U.S. employee stock purchase plan indicate broad access to equity as part of total reward. Company communications highlight attractive bonus and share plans that add meaningful upside beyond base pay.
-
Healthcare Strength — U.S. roles indicate strong health insurance and core protections, while official materials and country overviews reference private medical coverage and wellbeing support. These elements position the health package as a notable strength alongside cash compensation.
Oxford Nanopore Technologies Insights
What We Do
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
